This triple-agonist approach, targeting GLP-1, GIP, and glucagon receptors, produced the most dramatic weight loss results seen in any Phase 2 obesity trial
Better vasculature means more oxygen and nutrients reaching the healing site, which translates directly into faster, higher-quality repair
Common side effects may include: Dizziness Pain, swelling, or itching at the injection site Diarrhea Nausea Skin rash or acne-like skin Unwell or feeling of weakness Serious side effects may include: Difficulty breathing Swelling of the face, lips, or tongue Irregular heartbeats or palpitations Swelling or pain in the limbs due to blood clots Severe dizziness or weakness This list does not cover all potential side effects, and others may occur
Emideltide (opioid withdrawal, chronic insomnia, narcolepsy)